Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.55 HKD | +1.05% | +14.39% | -9.82% |
Apr. 17 | Innovent Appoints Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer | CI |
Apr. 02 | Hutchmed endometrial cancer treatment application accepted for review | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.82% | 7.9B | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+56.46% | 24.49B | |
-5.41% | 17.31B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
-44.23% | 11.26B | |
+7.57% | 8.31B |
- Stock Market
- Equities
- 1801 Stock
- News Innovent Biologics, Inc.
- Innovent Biologics' Q2 Revenue Reaches $148 Million; Shares Gain 9%